The ASSC Melanoma Screening Summit was held in Brisbane on Monday 25 March, 2019. Hosting over 150 registered delegates, the Summit aimed to develop a road map for reducing melanoma mortality in Australia through evaluation of new opportunities in early detection.
The invited speakers gave an overview of the current evidence, emerging trends and dilemmas with respect to the early detection of melanoma, and many of the presentations have been made available.
| Principles of screening and how it applies to melanoma | Professor David Whiteman
QIMR Berghofer Medical Research Institute |
| Over-diagnosis of melanoma | Dr Katy Bell
University of Sydney |
| Feasibility of population vs targeted screening | Professor Peter Baade
Cancer Council Queensland |
| Health economics of melanoma detection, diagnosis & treatment | Associate Professor Louisa Gordon
QIMR Berghofer Medical Research Institute |
| Some contributions to the evidence from Australia | Professor Joanne Aitken
Cancer Council Queensland |
| International perspective on melanoma screening | Professor Alexander Katalinic
University of Luebeck, Germany |
| Clinical Perspective: Acceptable absolutes and what to do with all the keratinocyte cancers | Professor Scott Menzies
University of Sydney |
| The role of whole body imaging & the opportunity for screening | Professor H. Peter Soyer
The University of Queensland |
| Impacts of AI and new technology for detection | Professor Susan Swetter
Stanford University, USA |
| Is pathology the gold standard for melanoma diagnosis | Professor Richard Scolyer
Melanoma Institute Australia |
| A population-based screening program versus opportunistic screening and early detection | Professor Sancy Leachman,
Oregon Health & Science University, USA |
| National requirements for the government to consider a screening program | Dr Jeanette Young
Queensland Government |
